Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Scalp cooling effectively reduces hair loss from chemotherapy.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Vijaya successfully fought stage 2A breast cancer with surgery, chemotherapy, radiotherapy, and hormone therapy, while advocating for support groups.

Some breast cancer chemotherapy can cause permanent hair loss.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Some patients using cold caps to prevent hair loss from chemotherapy got mild scalp injuries similar to frostbite.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Some chemotherapy can cause permanent hair loss.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

PLD is an effective and safer alternative for treating breast cancer.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.